Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
What is Mannitol Injection?
Mannitol is a white crystalline powder or free-flowing granules freely soluble in water. It is a sterile, non-pyrogenic solution of mannitol in water for injection available in a concentration of 20% in flexible plastic containers for administration by intravenous infusion only. It is chemically designated as D-mannitol, used for the promotion of diuresis before irreversible renal failure becomes established, as an antiglaucoma agent and as a renal function diagnostic aid.
Global Mannitol Injection Market Outlook
Increasing prevalence of trauma and kidney failure coupled with increasing geriatric population to drive the growth of mannitol injection market. Mannitol is the first drug of choice to treat acute glaucoma in veterinary medicine. It has been projected that there will be approximately 80 million people with glaucoma by 2020. Extensive use of mannitol over the last several decades has produced recorded adverse effects; this has led to switch to alternative. Ongoing research and trials for new treatment to fuel growth by 2026. The clinical trials found that treatment with mannitol for increased intracranial pressure reduced the likelihood of death will fuel the growth in future.
Global Mannitol Injection Market Competitive Landscape
The "Global Mannitol Injection Market" study report will provide a valuable insight with an emphasis on global market including some of the major players such as Hospira, Pfizer, B. Braun, Jiangsu Hengrui Medicine and Fresenius Kabi. Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis.
Customization of the Report
• In case of any queries or customization requirements please connect with our sales team, who will ensure that your requirements are met.
1. INTRODUCTION OF GLOBAL MANNITOL INJECTION MARKET
1.1. Overview of the Market
1.2. Scope of Report
1.3. Assumptions
2. EXECUTIVE SUMMARY
3. RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
3.1. Data Mining
3.2. Validation
3.3. Primary Interviews
3.4. List of Data Sources
4. GLOBAL MANNITOL INJECTION MARKET OUTLOOK
4.1. Overview
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Porters Five Force Model
4.4. Value Chain Analysis
5. GLOBAL MANNITOL INJECTION MARKET, BY PRODUCT TYPE
5.1. Overview
5.2. 5 g/100mL
5.3. 10 g/100mL
5.4. 15 g/100mL
5.5. 20 g/100mL
5.6. 25 g/100mL
6. GLOBAL MANNITOL INJECTION MARKET, BY DISTRIBUTION CHANNEL
6.1. Overview
6.2. Hospital Pharmacies
6.3. Retail Pharmacies
6.4. Online Pharmacies
7. GLOBAL MANNITOL INJECTION MARKET, BY GEOGRAPHY
7.1. Overview
7.2. North America
7.2.1. U.S.
7.2.2. Canada
7.2.3. Mexico
7.3. Europe
7.3.1. Germany
7.3.2. U.K.
7.3.3. France
7.3.4. Rest of Europe
7.4. Asia Pacific
7.4.1. China
7.4.2. Japan
7.4.3. India
7.4.4. Rest of Asia Pacific
7.5. Rest of the World
7.5.1. Latin America
7.5.2. Middle East & Africa
8. GLOBAL MANNITOL INJECTION MARKET COMPETITIVE LANDSCAPE
8.1. Overview
8.2. Company Market Ranking
8.3. Key Development Strategies
9. COMPANY PROFILES
9.1. Hospira
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments
9.2. Pfizer
9.2.1. Overview
9.2.2. Financial Performance
9.2.3. Product Outlook
9.2.4. Key Developments
9.3. B. Braun
9.3.1. Overview
9.3.2. Financial Performance
9.3.3. Product Outlook
9.3.4. Key Developments
9.4. Jiangsu Hengrui Medicine
9.4.1. Overview
9.4.2. Financial Performance
9.4.3. Product Outlook
9.4.4. Key Developments
9.5. Fresenius Kabi
9.5.1. Overview
9.5.2. Financial Performance
9.5.3. Product Outlook
9.5.4. Key Developments
10. Appendix
10.1. Related Reports